Withdrawal of Registration Statement (rw)
January 16 2015 - 12:54PM
Edgar (US Regulatory)
Axxess Pharma,
Inc.
3250 Bloor Street West, Suite 613
Toronto, ON, M8X 2X9
January 16, 2015
Securities and Exchange Commission
Division of Corporate Finance
100 F Street N.E
Washington, D.C. 20549
Attn: Pamela Long
| Re: |
Axxess Pharma, Inc. |
| |
Registration Statement on Form S-1 |
| |
Filed July 25, 2014 |
| |
File No. 333-197647 |
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities Act of 1933 (the “Act”),
Axxess Pharma, Inc. (the “Company”) requests the withdrawal of the Company’s Registration Statement on Form S-1
originally filed on July 25, 2014, File No. 333-197647 (the “S-1 Registration Statement”). The Company has elected
to withdraw the S-1 Registration Statement as we terminated certain investment agreement with certain selling stockholder and we
believe that a withdrawal of the S-1 Registration Statement was appropriate. No sales of the Company’s common stock have
been or will be made pursuant to the S-1 Registration Statement. The Company may in the future rely on Rule 155(c) for subsequent
private offerings of its securities and utilize the “Safe Harbor” from integration provided by Rule 155.
The Company requests that in accordance with Rule 457 (p) under
the Securities Act, all fees paid to the Commission in connection with the filing of the above-captioned registration statement
be credited for future use. If you have any questions regarding this application, please contact our legal counsel, Gregg E. Jaclin
at (609) 275-0400.
| |
Very truly yours, |
|
| |
|
|
| |
Axxess Pharma, Inc. |
|
| |
|
|
|
| |
By: |
/s/ Peter Daniel Bagi |
|
| |
|
Name: Peter Daniel Bagi, MD |
|
| |
|
Title: Chief Executive Officer and |
|
| |
|
Chief Financial Officer |
|
| |
|
(Principal Executive and Accounting Officer) |
|
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Apr 2023 to Apr 2024
